clexane 10,000 iu (100mg)/1ml solution for injection in pre-filled syringes
sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 100 milligram(s)/millilitre - heparin group; enoxaparin
eloxatin 5 mg/ml concentrate for solution for infusion
sanofi-aventis ireland limited t/a sanofi - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin
tarivid 200mg film-coated tablets
sanofi-aventis ireland limited t/a sanofi - ofloxacin - film-coated tablet - 200 milligram(s) - fluoroquinolones; ofloxacin
tavanic 5 mg/ml solution for infusion
sanofi-aventis ireland limited t/a sanofi - levofloxacin - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin
clexane 2,000 iu (20mg) /0.2 ml solution for injection in pre-filled syringes
sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 20 mg/ 0.2 millilitre(s) - heparin group; enoxaparin
clexane 4,000 iu (40mg) /0.4 ml solution for injection in pre-filled syringes
sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 40 milligram(s) - heparin group; enoxaparin
clexane 6,000 iu (60mg) /0.6 ml solution for injection in pre-filled syringes
sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 60 mg/ 0.6 millilitre(s) - heparin group; enoxaparin
clexane 8,000 iu (80mg) /0.8 ml solution for injection in pre-filled syringes
sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 80 milligram(s) - heparin group; enoxaparin
clexane forte 12,000 iu (120mg) / 0.8 ml solution for injection in pre-filled syringes
sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 120 milligram(s) - heparin group; enoxaparin
lemtrada
sanofi-aventis new zealand limited - alemtuzumab 10 mg/ml - concentrate for infusion - 10 mg/ml - active: alemtuzumab 10 mg/ml excipient: dibasic sodium phosphate disodium edetate dihydrate monobasic potassium phosphate polysorbate 80 potassium chloride sodium chloride - treatment of relapsing forms of multiple sclerosis (ms) for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.